|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.580 HKD | +0.35% |
|
+2.51% | +1.78% |
| 07-29 | CSPC Pharmaceutical Starts Phase 2 Trial of Hypertension Drug | MT |
| 07-29 | CSPC-Licensed Oropharyngeal Cancer Drug Cleared for U.S. Registrational Trial | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 11.89x | 2.27x | 0.14x | 2.44x | 6.81x | 9.43x | 4.33% | 12.46B | ||
| 34.3x | 20.95x | 0.73x | 12.25x | 25.74x | 26.76x | 0.59% | 1,030B | ||
| 27.42x | 6.96x | -1.78x | 6.27x | 17.37x | 18.9x | 2.1% | 617B | ||
| 32.4x | 12812.84x | 0.14x | 7.6x | 15.6x | 16.13x | 2.67% | 455B | ||
| 19.58x | 7.05x | 1.56x | 4.68x | 11.59x | 12.85x | 2.83% | 350B | ||
| 22.31x | 6.28x | -9.73x | 5.76x | 14.38x | 15.24x | 2.78% | 299B | ||
| 21.88x | 4.92x | 1.12x | 4.51x | 12.77x | 13.53x | 1.94% | 265B | ||
| 14.62x | 6.3x | -8.51x | 5.41x | 11.16x | 13.11x | 3.43% | 225B | ||
| 25.46x | 19.56x | 3.63x | 6.65x | 11.72x | 15.22x | 2.6% | 209B | ||
| -47.31x | 8.3x | 0.34x | 5.67x | 31.32x | 62.3x | 2.51% | 163B | ||
| 12.64x | 1.61x | 0.28x | 3.1x | 7.83x | 8.86x | 6.91% | 142B | ||
| 12.34x | 5.65x | 0.24x | 3.41x | 9.28x | 9.79x | 3.87% | 132B | ||
| 27.33x | 5.52x | 1.82x | 8.31x | 18.73x | 19.61x | -.--% | 122B | ||
| 14.88x | 1.16x | -0.63x | 2.09x | 6.81x | 7.51x | 5.64% | 101B | ||
| 12.77x | 7.33x | 1.66x | 2.77x | 8.37x | 9.17x | 3.59% | 104B | ||
| 22.93x | 5.18x | 1.35x | 7.71x | 14.64x | 15.32x | 1.94% | 72.96B | ||
| 46.62x | 1.23x | 86.14x | 2.77x | 9.35x | 28.49x | 3.57% | 57.26B | ||
| 20.94x | 1.7x | -0.13x | 1.74x | 8.27x | 13.88x | 0.47% | 54.79B | ||
| 39.2x | 5.24x | 2.16x | 8.87x | 29.44x | 30.77x | 0.49% | 53.29B | ||
| 18.79x | 1.92x | 3.11x | 3.45x | 12.91x | 14.48x | 2.15% | 43.65B | ||
| Average | 19.55x | 646.60x | 4.18x | 5.27x | 14.20x | 18.07x | 2.72% | 225.42B | |
| Weighted average by Cap. | 23.37x | 1,301.81x | 0.50x | 7.08x | 16.99x | 19.53x | 2.25% |
- Stock Market
- Stocks
- 1093 Stock
- Sector CSPC Pharmaceutical Group Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















